Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities, Ltd. et al > Summary
Court Case Number 1:22-cv-01611
Filing Date Dec 20, 2022
Termination Date Apr 3, 2024
Court Delaware District Court
Status Dismissed - Other
JudgesColm F. Connolly, Jennifer L. Hall
Plaintiff Attorneys
2Taiho Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Taiho Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Defendant Attorneys
Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Counter Defendant
8Taiho Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Taiho Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Taiho Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Taiho Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Taiho Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Taiho Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Taiho Pharmaceutical
Attorney Name: Steven J. Balick
Ashby & Geddes
Taiho Pharmaceutical
Attorney Name: Andrew C. Mayo
Ashby & Geddes
Counter Claimant
6Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10960004 | Method for treating cancer patients with severe renal impairment | Mar 30, 2021 |
| 10456399 | Method for treating cancer patients with severe renal impairment | Oct 29, 2019 |
